After announcing two distribution agreements at the end of last month, Venture Life Group (LON:VLG) has announced line extension deals with an existing partner.
The international consumer self-care group focused on serving the ageing population, has signed a second long-term distribution agreement with Elpen for the distribution rights to NeuroAge NRG and NeuroAge Sleep, the group's two new line extensions for the NeuroAge range.
Elpen already own the distribution rights to NeuroAge in Greece and launched NeuroAge in Greece in 2013. The market launch of NeuroAge NRG and NeuroAge Sleep in Greece is expected in the first quarter of 2015.
NeuroAge is a food supplement formulated to help support mental performance in a healthy brain. NeuroAge NRG and NeuroAge Sleep are new additions to the range, with the former specially formulated to maintain alertness while the latter, as the name suggests, helps people get to sleep.
“The signing of this agreement by Elpen is not only an endorsement of our product development strategy but it also reflects the strong start that NeuroAge has achieved in Greece since its market launch,” said Jerry Randall, chief executive officer of Venture Life.
On 25 June, the company announced new long-term distribution agreements with two distribution partners, covering four Venture Life products in three territories: NeuroAge NRG and NeuroAge Sleep with an existing partner in Romania and Moldova; ZipClear with a new partner in Turkey; and Calm-eze with a new partner in Turkey.